CLEC10A
Basic information
Region (hg38): 17:7074537-7080307
Previous symbols: [ "CLECSF13", "CLECSF14" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLEC10A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 2 |
Variants in CLEC10A
This is a list of pathogenic ClinVar variants found in the CLEC10A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-7075139-C-G | not specified | Uncertain significance (May 23, 2024) | ||
17-7075152-A-G | not specified | Uncertain significance (Jul 19, 2022) | ||
17-7075164-C-T | not specified | Uncertain significance (Jul 14, 2023) | ||
17-7075432-G-A | not specified | Uncertain significance (May 06, 2024) | ||
17-7075747-T-C | not specified | Uncertain significance (Nov 12, 2021) | ||
17-7075766-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
17-7075798-G-C | Benign (Jun 21, 2018) | |||
17-7075808-T-A | not specified | Uncertain significance (May 24, 2023) | ||
17-7075850-C-T | not specified | Uncertain significance (Jan 19, 2022) | ||
17-7076012-A-G | Benign (Jun 21, 2018) | |||
17-7076098-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
17-7076105-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
17-7076132-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
17-7076150-C-A | not specified | Uncertain significance (Dec 12, 2023) | ||
17-7076919-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
17-7076933-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
17-7078083-C-T | not specified | Likely benign (May 03, 2023) | ||
17-7078806-T-C | not specified | Uncertain significance (Jul 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLEC10A | protein_coding | protein_coding | ENST00000254868 | 8 | 5771 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000776 | 0.757 | 125666 | 0 | 81 | 125747 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.359 | 154 | 167 | 0.922 | 0.00000864 | 2068 |
Missense in Polyphen | 40 | 41.806 | 0.95681 | 587 | ||
Synonymous | 0.926 | 64 | 74.1 | 0.863 | 0.00000459 | 602 |
Loss of Function | 1.18 | 10 | 14.9 | 0.670 | 7.24e-7 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00107 | 0.00107 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000158 | 0.000158 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.000392 | 0.000392 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Probable role in regulating adaptive and innate immune responses. Binds in a calcium-dependent manner to terminal galactose and N-acetylgalactosamine units, linked to serine or threonine. These sugar moieties are known as Tn-Ag and are expressed in a variety of carcinoma cells. {ECO:0000269|PubMed:8598452}.;
- Pathway
- Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;Dectin-2 family;C-type lectin receptors (CLRs);Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.959
- rvis_EVS
- 1.22
- rvis_percentile_EVS
- 93.16
Haploinsufficiency Scores
- pHI
- 0.0573
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0908
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mgl2
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- stimulatory C-type lectin receptor signaling pathway;adaptive immune response;endocytosis;innate immune response
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- carbohydrate binding